Table 1.
Clinical Characteristics of the Study Patients with and without a Recurrent Acute Coronary Event during the Follow‐Up
| Without Recurrent Coronary Event (n = 577) | With Recurrent Coronary Event (n = 98) | P | |
|---|---|---|---|
| Age (years) | 61 ± 10 | 66 ± 9 | <0.001 |
| Male/female | 439/138 (76%/24%) | 64/34 (65%/35%) | 0.02 |
| Ejection fraction (%) | 45 ± 9 | 44 ± 9 | 0.10 |
| NYHA class, I/II/III | 411/107/59 (71%/19%/10%) | 55/21/22 (56%/21%/23%) | <0.01 |
| History | |||
| Diabetes | 123 (21%) | 36 (37%) | <0.01 |
| Previous AMI | 118 (20%) | 28 (29%) | 0.07 |
| Hypertension | 280 (49%) | 53 (54%) | 0.32 |
| Smoking | 385 (67%) | 71 (72%) | 0.26 |
| Type of AMI, Q/non‐Q/Int | 291/245/41 (50%/43%/7%) | 41/50/7 (42%/51%/7%) | 0.42 |
| Location of AMI, Ant/Inf/Int | 257/249/71 (45%/43%/12%) | 50/33/15 (51%/34%/15%) | 0.08 |
| Medication | |||
| β‐blockers | 559 (97%) | 92 (94%) | 0.06 |
| Statins | 200 (35%) | 36 (37%) | 0.72 |
| Aspirin | 483 (84%) | 75 (77%) | 0.06 |
| Warfarin | 60 (10%) | 17 (17%) | 0.04 |
| ACE/ATII‐inhibitors | 217 (38%) | 46 (47%) | 0.09 |
| Diuretic drugs | 138 (24%) | 32 (33%) | 0.07 |
| Digitalis | 31 (5%) | 12 (12%) | <0.05 |
| Ca‐blockers | 37 (6%) | 16 (16%) | <0.01 |
| Amiodarone | 9 (2%) | 3 (3%) | 0.30 |
The values are means ± SD or the number of the patients. ACE = angiotensin‐converting enzyme; AMI = acute myocardial infarction; ATII = angiotensin II; Ca = calcium; NYHA = New York Heart Association; Q/non‐Q/Int = Q‐wave/non‐Q‐wave/Indeterminate.